ANIK
Anika Therapeutics IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$212.71M
P/E Ratio
—
EPS
$-0.70
Beta
0.28
52W High
$15.18
52W Low
$7.87
50-Day MA
$12.28
200-Day MA
$10.30
Dividend Yield
—
Profit Margin
-9.64%
Forward P/E
59.52
PEG Ratio
5.94
About Anika Therapeutics Inc
Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally. The company is headquartered in Bedford, Massachusetts.
Fundamentals
| Revenue (TTM) | $112.82M |
| Gross Profit (TTM) | $63.81M |
| EBITDA | $-5.47M |
| Operating Margin | 2.11% |
| Return on Equity | -6.71% |
| Return on Assets | -3.52% |
| Revenue/Share (TTM) | $7.87 |
| Book Value | $10.33 |
| Price-to-Book | 1.39 |
| Price-to-Sales (TTM) | 1.89 |
| EV/Revenue | 1.486 |
| EV/EBITDA | 8.20 |
| Quarterly Earnings Growth (YoY) | -50.50% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $13.40M |
| Float | $11.34M |
| % Insiders | 5.41% |
| % Institutions | 92.98% |
Analyst Ratings
Consensus ($17.50 target)
1
Strong Buy1
BuyData last updated: 4/7/2026